These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 19387550

  • 1. Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery.
    Miyata Y.
    Cell Mol Life Sci; 2009 Jun; 66(11-12):1840-9. PubMed ID: 19387550
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37.
    Miyata Y, Nishida E.
    Mol Cell Biol; 2004 May; 24(9):4065-74. PubMed ID: 15082798
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.
    Xu W, Mollapour M, Prodromou C, Wang S, Scroggins BT, Palchick Z, Beebe K, Siderius M, Lee MJ, Couvillon A, Trepel JB, Miyata Y, Matts R, Neckers L.
    Mol Cell; 2012 Aug 10; 47(3):434-43. PubMed ID: 22727666
    [Abstract] [Full Text] [Related]

  • 6. Supervision of multiple signaling protein kinases by the CK2-Cdc37 couple, a possible novel cancer therapeutic target.
    Miyata Y, Nishida E.
    Ann N Y Acad Sci; 2004 Dec 10; 1030():150-7. PubMed ID: 15659792
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phosphorylation of serine 13 is required for the proper function of the Hsp90 co-chaperone, Cdc37.
    Shao J, Prince T, Hartson SD, Matts RL.
    J Biol Chem; 2003 Oct 03; 278(40):38117-20. PubMed ID: 12930845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
    Grover A, Shandilya A, Agrawal V, Pratik P, Bhasme D, Bisaria VS, Sundar D.
    BMC Bioinformatics; 2011 Feb 15; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation.
    Stetz G, Verkhivker GM.
    J Chem Inf Model; 2018 Feb 26; 58(2):405-421. PubMed ID: 29432007
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of the CK2-dependent phosphorylation of serine 13 in Cdc37 using a phospho-specific antibody and phospho-affinity gel electrophoresis.
    Miyata Y, Nishida E.
    FEBS J; 2007 Nov 26; 274(21):5690-703. PubMed ID: 17922836
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. How Hsp90 and Cdc37 Lubricate Kinase Molecular Switches.
    Verba KA, Agard DA.
    Trends Biochem Sci; 2017 Oct 26; 42(10):799-811. PubMed ID: 28784328
    [Abstract] [Full Text] [Related]

  • 19. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.
    Zhang H, Wu W, Du Y, Santos SJ, Conrad SE, Watson JT, Grammatikakis N, Gallo KA.
    J Biol Chem; 2004 May 07; 279(19):19457-63. PubMed ID: 15001580
    [Abstract] [Full Text] [Related]

  • 20. [Molecular chaperone HSP90 as a novel target for cancer chemotherapy].
    Miyata Y.
    Nihon Yakurigaku Zasshi; 2003 Jan 07; 121(1):33-42. PubMed ID: 12617036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.